Pharmaceuticals

Global Pharmaceutical Safety Assessment Market Set To Expand To $6.67 Billion By 2030 At 28.4% CAGR

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Pharmaceutical Safety Assessment Market Between 2026 And 2030?

The pharmaceutical safety assessment market has experienced significant growth in recent years. This market is forecast to expand from $11.32 billion in 2025 to $12.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. The historical increase in market size can be attributed to the enlargement of pharmaceutical R&D pipelines, heightened regulatory scrutiny on drug safety, a rise in preclinical and clinical testing volumes, the broader implementation of in-vitro safety assessment methods, and the increasing utilization of CRO-led safety studies.

The pharmaceutical safety assessment market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $16.97 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.5%. The projected growth during this period stems from several factors, including a greater dependence on computational methods for safety assessment, the broadening scope of personalized medicine development, an escalating need for expedited regulatory approvals, the increasing incorporation of AI into drug safety processes, and more stringent post-market surveillance mandates. Key trends anticipated during the forecast timeframe encompass the increasing deployment of AI-based tools for toxicity prediction, a growing embrace of in-silico safety assessment models, the expanded integration of real-time pharmacovigilance systems, the proliferation of automated preclinical testing platforms, and a heightened emphasis on safety analytics that adhere to regulatory standards.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp

Which Strong Drivers Are Impacting The Pharmaceutical Safety Assessment Market Growth?

The increased scale of clinical trials is anticipated to drive the future growth of the pharmaceutical safety assessment market. These trials represent research conducted on humans to evaluate the safety, efficacy, and side effects of new medical treatments, drugs, or interventions. The rise in clinical trials is due to the growing demand for new and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. Clinical trials bolster pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing essential data that regulatory authorities use to ensure that medications are both effective and safe for public use. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, as of September 26, 2025, a total of 554,798 studies were registered on ClinicalTrials.gov. Thus, the expansion of clinical trials is fueling the growth of the pharmaceutical safety assessment market.

Which Segment Classifications Are Used In The Pharmaceutical Safety Assessment Market Segment Analysis?

The pharmaceutical safety assessment market covered in this report is segmented –

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

What Trends Are Transforming The Pharmaceutical Safety Assessment Market?

Leading companies in the pharmaceutical safety assessment market are concentrating on developing AI-driven decision support tools to enhance the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that uses artificial intelligence to analyze data and provide insights, thereby supporting faster and more accurate decision-making. For instance, in April 2024, Charles River Laboratories, a US-based life sciences company, in partnership with Deciphex, an Ireland-based company that enhances diagnostic precision and speed through AI-driven quality assurance, launched the Patholytix Foresight platform. This AI-powered decision support tool is designed to transform toxicologic pathology in pharmaceutical safety assessment. The platform utilizes artificial intelligence to swiftly analyze complex preclinical pathology data, helping identify potential safety risks earlier and reducing subjectivity in results. It offers unique features such as an AI algorithm that detects tissue abnormalities, a cloud-based system for global collaboration, and a scalable design that cuts down slide review time while improving data accuracy and consistency.

Which Firms Are Contributing To The Pharmaceutical Safety Assessment Market Ecosystem?

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Get The Full Pharmaceutical Safety Assessment Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

Which Geographic Region Dominates The Pharmaceutical Safety Assessment Market?

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmaceutical Safety Assessment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-safety-assessment-global-market-report

Browse Through More Reports Similar to the Global Pharmaceutical Safety Assessment Market 2026, By The Business Research Company

Pharmaceutical Chemicals Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Pharmacovigilance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795